Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - In All Potencies Except 2.5 Mg Per Divided Oral Dosage Form)
Deadline - Apr 30, 2026
GT reference number - 82028998
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 82028998
Document Type - Tender Notices
Description - Description: Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - In All Potencies Except 2.5 Mg Per Divided Oral Dosage Form)local title:: Arzneimittel mit dem Wirkstoff Rivaroxaban (ATC: B01AF01 - in allen Wirkstärken außer 2,5 mg je abgeteilte orale Darreichungsform)type_of_procedure: Otherbidding_response_method: Not Available
Gt Ref Id - 82028998
Deadline - Apr 30, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database